Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

997
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
997
Sex-linked Disorders01:43

Sex-linked Disorders

110.7K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
110.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect.

The Journal of general physiology·2026
Same author

Compensatory rearrangement of parvalbumin interneuron voltage-gated sodium channel subunits in a mouse model of Dravet syndrome.

Epilepsia·2026
Same author

White Matter Microstructural Abnormalities in Neonatal Onset Genetic Epilepsy.

Annals of clinical and translational neurology·2026
Same author

Author Correction: Biallelic variants in the noncoding RNA gene RNU4-2 cause a recessive neurodevelopmental syndrome with distinct white matter changes.

Nature genetics·2026
Same author

In vivo adenine base editing ameliorates Dravet syndrome phenotypes in a mouse model.

Science translational medicine·2026
Same author

Stratification of Phenotypes in Childhood-Onset <i>COL4A1/COL4A2</i>-Related Disorders Based on Age of Presentation.

Neurology. Genetics·2026

Related Experiment Video

Updated: Mar 24, 2026

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.8K

Characterizing SCN1A-Related Disorders Using Real-World Data Across 681 Patient-Years.

Anna J Prentice1,2, Ian McSalley1,2,3, Jan H Magielski1,2,3

  • 1Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA, 19104.

Medrxiv : the Preprint Server for Health Sciences
|March 23, 2026
PubMed
Summary
This summary is machine-generated.

SCN1A-related disorders, a common cause of epilepsy, were analyzed using real-world clinical data to detail their longitudinal disease history. This study provides a granular view of seizure types, comorbidities, and treatments, refining natural history data for better clinical trial outcomes.

Keywords:
Dravet syndromeEpilepsySCN1Adevelopmental and epileptic encephalopathygeneticsneurogenetics

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies &#8212; Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

2.8K

Related Experiment Videos

Last Updated: Mar 24, 2026

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

9.8K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies &#8212; Genetic Models and Behavioral Tests
08:30

Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests

Published on: September 6, 2024

2.8K

Area of Science:

  • Genetics and Neurology: Focuses on monogenic epilepsy causes and neurodevelopmental disorders.
  • Real-World Data Analysis: Utilizes electronic health records for longitudinal disease tracking.
  • Precision Medicine: Investigates SCN1A variants and their impact on epilepsy phenotypes.

Background:

  • SCN1A-related disorders are the most frequent monogenic cause of epilepsy.
  • Real-world data analysis complements prospective studies, enhancing scale and duration of available data.
  • Understanding the longitudinal disease history is crucial for developing meaningful clinical trial outcomes.

Purpose of the Study:

  • To delineate the longitudinal disease history of 100 individuals with SCN1A-related disorders using real-world data.
  • To systematically map clinical terms and assess seizure burden, comorbidities, and treatment patterns over time.
  • To refine existing natural history data for SCN1A-related disorders.

Main Methods:

  • Systematic analysis of real-world data from 100 individuals with SCN1A-related disorders.
  • Mapping 671 unique clinical terms to a standardized framework in monthly increments over 681 patient-years.
  • Annotating seizure type and frequency in monthly time-bins to assess seizure burden and track developmental and EEG findings.

Main Results:

  • Identified a median of 17 changes in seizure frequency and ten seizure types per participant.
  • Observed high frequency of myoclonic seizures (median >5 daily) and rarer occurrences of other seizure types.
  • Found neurodevelopmental differences in 83% of individuals, with 69% experiencing delayed language skills; motor impairments in 69%.
  • Documented unique medication landscapes for different syndromes, with treatment changes post-diagnosis (e.g., increased cannabidiol, clobazam, fenfluramine).

Conclusions:

  • Reconstructed the longitudinal disease history of SCN1A-related disorders using a standardized framework for real-world clinical data.
  • Provided a granular landscape of seizures, comorbidities, and treatment approaches over time, refining natural history data.
  • Highlighted the utility of real-world data in understanding complex epilepsy syndromes like those associated with SCN1A.